News and Trends 1 May 2019Next-Generation CAR-T Therapy Shows Promise in Child’s Neuroblastoma Cell Medica’s next-generation CAR-T cell therapy has resulted in 'extensive tumor regression' in a child with high-risk neuroblastoma, one… May 1, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 27 Feb 2019UK Biotech Gets Huge Grant to Launch Off-the-Shelf CAR-T Cancer Therapy to Clinic The UK biotech Cell Medica has received a €7.6M ($8.7M) grant from the Cancer Prevention and Research Institute of Texas… February 27, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Feb 2018Money, Money, Money! Europe’s Best-Funded Biotechs in 2018 Besides struggling with ambitious New Year’s resolutions and post-holiday diets, January is a time where many of us re-examine our… February 20, 2018 - 11 minutesmins - By Karen O’Hanlon Cohrt Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jun 2017British Biotech Tops up its Cancer Pipeline with New TCR Therapy Cell Medica just acquired Catapult Therapy TCR, set up by UK's CGT Catapult, gaining the rights to its TCR therapy… June 21, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 16 Mar 2017UK Immunotherapy Biotech raises Massive Funding in Series C The UK biotech Cell Medica picked up a massive €69M (£60M) in its recent Series C funding round to advance its… March 16, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 21 Feb 2017New Immunotherapy Candidate receives FDA Fast Track Designation Cell Medica's Orphan Drug CMD-003 has received fast track designation by the FDA to advance immunotherapy of patients with Epstein Bar Virus… February 21, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email